Amiodarone-induced pulmonary hemorrhage

Southern Medical Journal

Volumn 99, Issue 4, 2006, Pages 329-330

  Singh, Sonal ^a,b,c  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLUCOCORTICOID; PHOSPHOLIPID DERIVATIVE; SURFACTANT PROTEIN D;

BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL FEATURE; EDITORIAL; HEART ATRIUM ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG HEMORRHAGE; LUNG NODULE; LUNG TOXICITY; PATHOPHYSIOLOGY; THORAX RADIOGRAPHY;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; HEMORRHAGE; HUMANS; LUNG DISEASES; PULMONARY ALVEOLI; RESPIRATORY FUNCTION TESTS; TACHYCARDIA, VENTRICULAR;

EID: 33646486859     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000209228.50911.a8     Document Type: Editorial

References (22)

1. Gill J, Heel RC, Fitton A. Amiodarone: an overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 1992;43:69-110.
2. Ravishankar R, Samuels LE, Kaufman MS, et al. Amiodarone-associated hemoptysis. Am J Med Sci 1998;316:390-392.
3. Sunderji R, Kanji Z, Gin K. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance. Can J Cardiol 2000;16:1435-1440.
4. Martin II, WJ Rosenow EC III. Amiodarone pulmonary toxicity: recognition and pathogenesis (part I). Chest 1988;93:1067-1075.
5. Handschin AE, Lardinois D, Schneiter D, et al. Acute amiodarone-induced pulmonary toxicity following lung resection. Respiration 2003;70:310-312.
6. Morady F, Sauve MJ, Malone P, et al. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol 1983;52:975-979.
7. Conte SC, Pagan V, Murer B. Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: clinical, radiological and histological pattern. Monaldi Arch Chest Dis 1997;52:24-26.
8. Rodriguez-Garcia JL, Garcia-Nieto JC, Ballesta F, et al. Pulmonary mass and multiple lung nodules mimicking a lung neoplasm as amiodarone-induced pulmonary toxicity. Eur J Intern Med 2001;12:372-376.
9. Bernal Morell E, Hernandez Madrid A, Marin Marin I, et al. Multiple pulmonary nodules and amiodarone: KL-6 as a new diagnostic tool. Rev Esp Cardiol 2005;58:447-449.
10. Goldstein I, Topilsky M, Segev D, et al. Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. Chest 1997;111:1446-1447.
11. Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol 2002;89:896-898.
12. Ulrik CS, Aldershvile J. Early diagnosis of amiodarone-induced pulmonary toxicity: Are repeated lung function tests of any value? Ugeskr Laeger 1996;158:3445-3447.
13. Ulrik CS, Backer V, Aldershvile J, Pietersen AH. Serial pulmonary function tests in patients treated with low-dose amiodarone. Am Heart J 1992;123:1550-1554.
14. Oyama N, Oyama N, Yokoshiki H, et al. Detection of amiodarone-induced pulmonary toxicity in supine and prone positions: high-resolution computed tomography study. Circ J 2005;69:466-470.
15. Martin II, WJ Standing JE. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects. J Pharmacol Exp Ther 1988;244:774-779.
16. Endoh Y, Hanai R, Uto K, et al. KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity. Am J Cardiol 2000;86:229-231.
17. Endoh Y, Hanai R, Uto K, et al. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity. Pacing Clin Electrophysiol 2000;23:2010-2013.
18. Umetani K, Abe M, Kawabata K, et al. SP-D as a marker of amiodarone-induced pulmonary toxicity. Intern Med 2002;41:709-712.
19. Devine PL, Siebert WJ, Morton SL, et al. Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity. Dis Markers 1998;14:169-175.
20. Jessurun GA, Boersma WG, Crijns HJ. Amiodarone-induced pulmonary toxicity: predisposing factors, clinical symptoms and treatment. Drug Saf 1998;18:339-344.
21. Iskandar S, Abi-Saleh B, Keith R, et al. Amiodarone-induced alveolar hemorrhage. South Med J 2006;99:383-387.
22. Vizioli LD, Cho S. Amiodarone-associated hemoptysis. Chest 1994;105:305-306.